ENSG00000291006 and ovarian cancer: When ovarian cancer cells were treated with cisplatin or niraparib alone, respectively, the proliferation inhibition rate of ovarian cancer cells with knockdown of LOC730101 was lower than that of the control group; whereas when ovarian cancer cells were treated with the autophagy inhibitor 3-MA alone, the proliferation inhibition rate of ovarian cancer cells with knockdown of LOC730101 did not change compared to the control group, therefore 3-MA did not significantly inhibit cell proliferation.